Approval · Notice of Compliance 12013 · 2011
OLEPTRO: Notice of Compliance 12013
Issued January 19, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12013
- Date
- January 19, 2011
- Company
- Labopharm Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antidepressant
Products in this notice
Medicinal ingredients
- TRAZODONE HCL 150 MG per TAB
- TRAZODONE HCL 300 MG per TAB